2026 ICD-10-CM Diagnosis Code P09.3Abnormal findings on neonatal screening for congenital hematologic disorders
ICD-10-CM Codes›P00–P96›P09›P09
- Billable — Valid for Submission
- Not Chronic
P09.3 is a billable ICD-10-CM diagnosis code for abnormal findings on neonatal screening for congenital hematologic disorders. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 947 through 948. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified congenital anomalies and Other specified and unspecified perinatal conditions.
Code Identity
Code Classification
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- Abnormal findings for hemoglobinopathy screening
- Abnormal findings on red cell membrane defects screen
- Abnormal findings on sickle cell screen
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
Abnormal, abnormality, abnormalities See Also: Anomaly;
hemoglobinopathy P09.3
sickle cell P09.3
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Code History & ChangesHistory
Replacement P09.3 replaces the following previously assigned code(s):
- P09 - Abnormal findings on neonatal screening
Questions About P09.3Overview
Is P09.3 (Abnormal findings on neonatal screening) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report abnormal findings on neonatal screening for congenital hematologic disorders on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does P09.3 group to?
When abnormal findings on neonatal screening for congenital hematologic disorders is the principal diagnosis on an inpatient stay, it groups to MS-DRG 947, 948, with relative weights from 0.8005 to 1.2694 depending on complications. Higher weights mean higher Medicare reimbursement.